A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

NCT00642668 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta

Sponsor

Hoffmann-La Roche